NCT02942992 is a NA clinical trial of Resistance exercise in Sarcopenia, sponsored by Northwestern University.

Who is sponsoring NCT02942992?

NCT02942992 is sponsored by Northwestern University.

What drugs are being tested in NCT02942992?

Interventions in NCT02942992: Resistance exercise.

What condition does NCT02942992 study?

NCT02942992 studies Sarcopenia.

Is NCT02942992 still recruiting?

NCT02942992 is currently completed. Last updated 13 March 2019.

Last reviewed 2019-03-13 · How we verify

NCT02942992

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Implementing Resistance Exercise to Reduce Frailty for Older Adult

Completed NA Last updated 13 March 2019

What this trial tests

NA trial testing Resistance exercise in Sarcopenia in 126 participants. Completed in 31 July 2018.

Timeline

30 March 2017

Primary endpoint
8 August 2017

31 July 2018

Quick facts

Lead sponsor	Northwestern University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	126
Start date	30 March 2017
Primary completion	8 August 2017
Estimated completion	31 July 2018
Sites	1 location across United States

Drugs / interventions tested

Resistance exercise

Conditions studied

Sarcopenia — all drugs for Sarcopenia →

Sponsor

Northwestern University

Who can join

Adults 65 to 100, any sex, with Sarcopenia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To develop an intervention specifically targeted for these clients who have the frailty syndrome. The Investigators propose to develop an exercise intervention that can reduce frailty in older adults to facilitate their ability to age-in-place. The long-term objective of this work is to develop a package of interventions that can be administered within the existing Medicaid Home and Community Based Services (HCBS) Waiver programs. The specific goal of this proposal is to develop a resistance exercise intervention to reduce frailty in older adults receiving long term care services in their home through the Illinois Community Care Program, a HCBS Waiver Program.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Design and development of a mobile exercise application for home care aides and older adult medicaid home and community-based clients.
Danilovich MK, Diaz L, Saberbein G, Healey WE, et al · · 2017 · cited 8× · PMID 28937931 · DOI 10.1080/01621424.2017.1381869
Functional resistance activities to impact frailty: A protocol for a randomized controlled trial involving home care aide and frail older adult dyads.
Danilovich MK, Diaz L, Ciolinio JD, Corcos DM. · · 2017 · cited 7× · PMID 29696165 · DOI 10.1016/j.conctc.2017.05.006

Verify or expand the search:

Other trials of Resistance exercise

Trials testing the same drug.

NCT07288905 — Exploring the Effects of Exercise Combined With BFRT on Healthy and Patients With CKD · NA · recruiting
NCT06885736 — LEAN Mass Preservation With Resistance Exercise and Protein During Semaglutide/Tirzepatide Therapy · NA · recruiting
NCT07003802 — Neural Control and Mechanosensation in Spine Muscle · NA · enrolling by invitation
NCT07035327 — Dual-task Training for Frail Older Adults With Chronic Musculoskeletal Pain (Pilot) · NA · completed
NCT06813092 — Effects of Resistance Exercise Compared to Whole-body Electromyostimulation in Young Female Dentists. · NA · completed

Other recruiting trials for Sarcopenia

Currently open trials in the same condition.

NCT07500376 — Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery · recruiting
NCT07456956 — HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke · NA · recruiting
NCT07398495 — Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia · NA · recruiting
NCT07494916 — Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia · NA · active not recruiting
NCT07426159 — AI-Guided Sarcopenia Risk Assessment and Detection · NA · active not recruiting

Other Northwestern University trials

Trials by the same sponsor.

NCT06545695 — Epidermal Growth Factor Receptor Inhibition for Keratinopathies · Phase 1, PHASE2 · not yet recruiting
NCT07261657 — N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive C · EARLY_PHASE1 · not yet recruiting
NCT07392775 — ALDH2 Genetic Testing in East Asian Community · NA · not yet recruiting
NCT06886776 — Implementing A Secure Firearm Storage Program in Illinois Health Centers in Partnership With AllianceChicago and the Ill · NA · not yet recruiting
NCT07469176 — Co-Designing and Evaluating Additional Mothers and Babies Program Content for Expectant and New Parents of Children With · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02942992 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Northwestern University
Last refreshed: 13 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02942992.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing